The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis

Published:2020-08-01 Issue:8 Volume:34 Page:795-804
ISSN:0892-7790
Container-title:Journal of Endourology
language:en
Short-container-title:Journal of Endourology

Author:

Krajewski Wojciech¹,Nowak Łukasz¹,Poletajew Sławomir²,Tukiendorf Andrzej³,Moschini Marco⁴,Mari Andrea⁵⁶,Di Trapani Ettore⁷,Xylinas Evanguelos⁸,Kiełb Paweł¹,Wełna Marek⁹,Zdrojowy Romuald¹

Affiliation:

1. Department of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, Poland.

2. Second Department of Urology, Centre of Postgraduate Medical Education, Warsaw, Poland.

3. Department of Public Health, Wrocław Medical University, Wrocław, Poland.

4. Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland.

5. Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

6. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

7. European Institute of Oncology, Milan, Italy.

8. Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France.

9. Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Wroclaw, Poland.

Publisher

Mary Ann Liebert Inc

Subject

Urology

Link

https://www.liebertpub.com/doi/pdf/10.1089/end.2020.0301

Reference27 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

3. Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

4. Pattern of Recurrence Changes in Noninvasive Bladder Tumors Observed During 2 Decades

5. Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of VI-RADS scoring criteria for predicting oncological outcomes in bladder cancer;World Journal of Urology;2024-07-24

2. Clinical and pathological predictors of persistent T1 HG at second resection;Urologia Journal;2023-06-21

3. Intravesical Contrast-Enhanced MRI: A Potential Tool for Bladder Cancer Surveillance and Staging;Current Oncology;2023-04-30

4. Does repeat transurethral resection of bladder tumor influence the diagnosis and prognosis of T1 bladder cancer? A systematic review and meta-analysis;European Journal of Surgical Oncology;2023-01

5. A longitudinal single center analysis of T1HG bladder cancer: An 18 year experience;Urologic Oncology: Seminars and Original Investigations;2022-11